KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Operating Leases (2019 - 2026)

Teladoc Health's Operating Leases history spans 8 years, with the latest figure at $31.7 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 6.1% to $31.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $31.7 million, a 6.1% decrease, with the full-year FY2025 number at $34.2 million, up 6.44% from a year prior.
  • Operating Leases hit $31.7 million in Q1 2026 for Teladoc Health, down from $34.2 million in the prior quarter.
  • Over the last five years, Operating Leases for TDOC hit a ceiling of $50.7 million in Q1 2024 and a floor of $31.7 million in Q1 2026.
  • Historically, Operating Leases has averaged $40.1 million across 5 years, with a median of $40.2 million in 2022.
  • Biggest five-year swings in Operating Leases: soared 41.16% in 2024 and later plummeted 33.36% in 2025.
  • Tracing TDOC's Operating Leases over 5 years: stood at $38.0 million in 2022, then grew by 12.6% to $42.8 million in 2023, then fell by 24.98% to $32.1 million in 2024, then increased by 6.44% to $34.2 million in 2025, then fell by 7.21% to $31.7 million in 2026.
  • Business Quant data shows Operating Leases for TDOC at $31.7 million in Q1 2026, $34.2 million in Q4 2025, and $48.0 million in Q3 2025.